Immunology and Inflammation Research Group, Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.
Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1(Suppl 1):E86-93. doi: 10.1111/j.1749-6632.2010.05711.x.
The etiologies of the inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) have not been fully elucidated. However, there is very good evidence implicating T cell and T cell trafficking to the gut and its associated lymphoid tissue as important components in disease pathogenesis. The objective of this review is to provide an overview of the mechanisms involved in naive and effector T cell trafficking to the gut-associated lymphoid tissue (GALT; Peyer's patches, isolated lymphoid follicles), mesenteric lymph nodes and intestine in response to commensal enteric antigens under physiological conditions as well as during the induction of chronic gut inflammation. In addition, recent data suggests that the GALT may not be required for enteric antigen-driven intestinal inflammation in certain mouse models of IBD. These new data suggest a possible paradigm shift in our understanding of how and where naive T cells become activated to yield disease-producing effector cells.
炎症性肠病(IBD;克罗恩病、溃疡性结肠炎)的病因尚未完全阐明。然而,有充分的证据表明,T 细胞及其向肠道和相关淋巴组织的迁移是疾病发病机制中的重要组成部分。本篇综述的目的是概述在生理条件下以及在慢性肠道炎症的诱导下,针对共生肠内抗原,幼稚 T 细胞和效应 T 细胞向肠道相关淋巴组织(派尔集合淋巴结、孤立淋巴滤泡)、肠系膜淋巴结和肠道迁移的机制。此外,最近的数据表明,在某些 IBD 的小鼠模型中,GALT 可能不是肠内抗原驱动的肠道炎症所必需的。这些新数据表明,我们对幼稚 T 细胞如何以及在何处被激活产生致病效应细胞的理解可能会发生范式转变。